Lori Devlin, DO, MHA
Assistant Professor, Pediatrics
University of Louisville School of Medicine
April 22, 2014
Neonatal Abstinence Syndrome is a withdrawal syndrome that occurs in newborns after birth. The classic presentation is associated with opioid use during pregnancy. The incidence of Neonatal Abstinence Syndrome has substantially increased over the last over the last 10 years which has led to a significant increase in healthcare utilization and expenditures.
This session will provide physicians and other clinicians involved in the treatment of opiate use disorder with an overview of the incidence of Neonatal Abstinence Syndrome, the clinical presentation of Neonatal Abstinence Syndrome, and treatment options for this syndrome. Short and long-term outcome data for infants who have undergone NAS will also be reviewed. Integration of this information into clinical practice will better prepare physicians and other clinicians to educate pregnant women on the expectant clinical course for their infants after delivery.